News - BioHarvest Sciences

News Room

September 16, 2026

BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product

September 14, 2026

BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 3, 2026

BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

August 11, 2026

BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update

August 11, 2026

BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance

July 29, 2026

BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference

July 15, 2026

BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis

July 13, 2026

BioHarvest Sciences to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC

June 18, 2026

BioHarvest Sciences to Present at the 2026 BIO International Convention

May 18, 2026

TATE & LYLE EXPANDS COLLABORATION WITH BIOHARVEST SCIENCES TO ACCELERATE NEXT-GENERATION SWEETENER INNOVATION

May 14, 2026

BioHarvest Sciences Reports First Quarter 2026 Financial Results

May 13, 2026

BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications

May 12, 2026

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using its Proprietary Botanical Synthesis Platform

April 29, 2026

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate “Two-Lens” Growth Strategy

March 31, 2026

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

March 31, 2026

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

March 26, 2026

BioHarvest Sciences Announces that VINIA is now the No.1 Resveratrol Polyphenol Brand in the United States

March 17, 2026

BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

March 5, 2026

BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy

March 3, 2026

BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026

January 7, 2026

BioHarvest Sciences Issues Year End Shareholder Letter

December 18, 2025

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

December 3, 2025

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

November 16, 2025

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

November 13, 2025

BIOHARVEST SCIENCES ANNOUNCES CLOSING OF $19.9 MILLION UPSIZED PUBLIC OFFERING OF COMMON STOCK AND EXERCISE OF UNDERWRITER’S OPTION TO PURCHASE ADDITIONAL SHARES

November 6, 2025

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

October 30, 2025

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

September 22, 2025

BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and additional $3.8 Million in Debt Reduction

September 10, 2025

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

September 2, 2025

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

August 11, 2025

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

August 4, 2025

BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

July 23, 2025

BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025

June 4, 2025

BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles

May 21, 2025

BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound

May 16, 2025

BioHarvest Sciences Reports First Quarter 2025 Financial Results

May 12, 2025

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

May 1, 2025

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

April 1, 2025

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

March 6, 2025

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

March 4, 2025

BioHarvest In Vitro testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

February 18, 2025

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

February 12, 2025

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar

February 11, 2025

BioHarvest Sciences Announces Voluntary Delisting from CSE

January 22, 2025

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

January 8, 2025

BioHarvest Issues Shareholder Letter and Provides Corporate Update

December 11, 2024

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of  Ingredients through Botanical Synthesis Technology

November 25, 2024

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

November 25, 2024

BioHarvest Launches VINIA SuperFood Functional Tea Line

November 21, 2024

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

November 18, 2024

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 p.m. Eastern Time

November 12, 2024

BioHarvest Sciences Begins Trading on the Nasdaq Global Market

November 7, 2024

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

October 28, 2024

BioHarvest Sciences Appoints Bar Dichter as CFO

October 23, 2024

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

October 16, 2024

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

September 20, 2024

BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board

September 12, 2024

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

September 4, 2024

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

August 29, 2024

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

August 28, 2024

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA® Inside

August 23, 2024

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time

June 28, 2024

BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes

June 24, 2024

BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024

June 21, 2024

BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes

June 12, 2024

BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024

June 6, 2024

BioHarvest Sciences Announces Record $2 Million Monthly Sales

June 3, 2024

BIOHARVEST SCIENCES INC. ANNOUNCES COMPLETION OF CONSOLIDATION

May 30, 2024

BioHarvest Sciences Reports First Quarter 2024 Financial Results

May 30, 2024

BIOHARVEST SCIENCES INC. ANNOUNCES SHAREHOLDER APPROVAL OF SHARE CONSOLIDATION

May 1, 2024

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 p.m. Eastern Time

April 30, 2024

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

April 16, 2024

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity

April 4, 2024

BioHarvest Sciences Announces Conversion of Debt Notes

March 21, 2024

BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables

March 15, 2024

BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024

March 13, 2024

BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit

March 7, 2024

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024

March 7, 2024

BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time

February 26, 2024

BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via its Newly Launched Botanical Synthesis CDMO Business Unit.

February 15, 2024

BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

February 12, 2024

BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference

January 8, 2024

BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update

December 27, 2023

BIOHARVEST SCIENCES INC. CLOSES FINAL TRANCHE OF OVERSUBSCRIBED $13.5M PRIVATE PLACEMENT

December 13, 2023

BIOHARVEST SCIENCES ANNOUNCES MAJOR PRODUCT LAUNCH OF VINIA-BASED FUNCTIONAL COFFEES

December 1, 2023

BIOHARVEST SCIENCES TO HOST VIRTUAL SHAREHOLDER UPDATE DECEMBER 13, 2023, 2:30pm ET

November 29, 2023

BIOHARVEST SCIENCES REPORTS Q3 2023 REVENUE DEMONSTRATING CONTINUED GROWTH MOMENTUM

October 30, 2023

BIOHARVEST SCIENCES INC. ANNOUNCES $11.78M RAISED IN FIRST TRANCHE OF $13.5M PRIVATE PLACEMENT

October 10, 2023

HEALTH CANADA GRANTS BIOHARVEST SCIENCES LICENSE FOR VINIA SALES IN CANADA

September 6, 2023

BIOHARVEST ANNOUNCES AUGUST 2023 U.S. VINIA SALES EXCEEDED USD $1MILLION

August 30, 2023

BIOHARVEST SCIENCES REPORTS Q2 2023 RESULTS DEMONSTRATING CONTINUED GROWTH MOMENTUM

August 24, 2023

BIOHARVEST SCIENCES TO HOST VIRTUAL SHAREHOLDER PRESENTATION SEPTEMBER 6, 2023, 2:30 PM ET

July 18, 2023

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF CONVERTIBLE NOTES

June 27, 2023

BioHarvest Sciences Chief Medical Officer to speak at Collision Conference in Toronto

June 26, 2023

BioHarvest Participates at Major Jefferies Investment Conference Tuesday June 27

June 21, 2023

BioHarvest Unveils New Consumption Categories for its Flagship Product VINIA

June 6, 2023

BIOHARVEST SCIENCES ADDS RENOWNED SCIENTIST TO SCIENTIFIC ADVISORY BOARD

May 31, 2023

BIOHARVEST REPORTS Q1 2023 RESULTS DEMONSTRATING STRONG YEAR OVER YEAR GROWTH

May 4, 2023

BioHarvest adds over 25,000 US customers in last 365 days and congratulates NFL “Team VINIA” prospects on Draft Day success

May 3, 2023

BioHarvest Sciences and VINIA recognized as “World Changing Idea” by Fast Company

April 27, 2023

BIOHARVEST SCIENCES CONTRIBUTING VINIA FOR NFL TRAINING CAMP PREPARATION

April 26, 2023

BIOHARVEST SCIENCES TO HOST VIRTUAL SHAREHOLDER PRESENTATION MAY 4, 2 PM

April 19, 2023

BIOHARVEST SCIENCES ADDS DR. ILANA BELZER AS CHIEF OPERATING OFFICER

April 4, 2023

BIOHARVEST SCIENCES ANNOUNCES MAJOR MEDIA CAMPAIGN TO FOCUS ON VINIA REAL STORIES

VANCOUVER, BC and REHOVOT, ISRAEL, April 4, 2023 – BioHarvest Sciences (CSE:BHSC) (OTCQB:CNVCF) (the Company) is announcing that its first major 2023 product marketing…

February 21, 2023

BIOHARVEST SCIENCES ANNOUNCES A PRIVATE PLACEMENT OF UP TO CAD $8M OF CONVERTIBLE NOTES TO GROW CORE BUSINESS

VANCOUVER, CANADA, AND REHOVOT, ISRAEL, February 21, 2023 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTC:CNVCF) announced today…